Ipsen will fund research in proliferative and degenerative diseases.
Ipsen plans to create the Ipsen Life Sciences Program at the Salk Institute. The partners expects the program to contribute to advances in the field of proliferative and degenerative diseases through fundamental and applied biology research.
Ipsen and The Salk Institute for Biological Studies signed a memorandum of understanding was to establish the framework for this mission. The Ipsen Life Sciences Program will sponsor three categories of research programs over the next five years through targeted, core, and innovation grants.
Ipsen will provide funding for targeted research programs carried out at The Salk Institute in the field of proliferative diseases with a particular emphasis on novel therapeutic concepts for the treatment of pituitary adenomas.
Core grants will support basic research on chronic inflammation to malignant diseases such as cancer, loss of cognitive functions, movement disorders, and metabolic syndromes. Innovation grants will fund the exploration of advanced scientific concepts.
